Free to Breathe has a new funding opportunity solely focused on research to prevent or stop lung cancer metastasis. The foundation will only consider Letters of Intent proposing research to prevent or stop lung cancer metastasis including a clear vision and plan for clinical translation within three years.
- Letter of intent deadline: November 7th, 2014
- Invitation for submission of full application: January 7th, 2015
- Full application deadline: March 9th, 2015
- Applicant notification: May 15th, 2015
- Anticipated funding start date: June 1st, 2015
Visit the Free to Breathe website more information.
- Internal Deadline: September 8, 2014
- NSF Preliminary Proposal Deadline: October 21, 2014
- Final Proposals (by invitation) Deadline: May 15, 2015
Partnerships for International Research and Education (PIRE) is an NSF-wide program that supports international activities across all NSF supported disciplines. The primary goal of PIRE is to support high quality projects in which advances in research and education could not occur without international collaboration. PIRE seeks to catalyze a higher level of international engagement in the U.S. science and engineering community. PIRE promotes excellence in science and engineering through international collaboration and facilitates development of a diverse, globally-engaged, U.S. science and engineering workforce.
This PIRE competition will be open to all areas of science and engineering research which are supported by the NSF.
There are no restrictions or limits on who can serve as a PI as long as they have or request PI status through Boston University. Proposals may be submitted by U.S. academic institutions with Ph.D.-granting programs that have awarded doctoral degrees in the 2012 or 2013 academic years in any area of research supported by NSF. Note that universities are limited to one proposal as the lead institution. There is no limit on the number of proposals in which an institution can participate as a partner. Full proposals will be accepted by invitation only. For the purposes of this opportunity, Boston University and Boston University Medical Campus will be considered separate institutions allowing one preliminary proposal from each.
NSF intends to award a total of $10 million-$15 million for this round of PIRE. Pending the availability of funds, NSF will make average awards of approximately $4 million over five years. Additional funding for international partners on PIRE projects may be available from selected NSF counterpart agencies abroad.
BUMC may submit only one application to the PIRE program. Potential applicants will be reviewed internally to select the final candidate. If you would like to apply, please email the following documents (preferably combined into a single pdf file) to Diana Lehman (email@example.com), Office of Clinical Research by September 8, 2014:
- a one-page project summary describing the concept of the proposed PIRE project, including why the international partnership is critical to the project success and the broader impacts of the project
- Junior faculty (instructors and assistant professors should include a support letter from their research mentors
- your email address and your mentor’s email address
- your biosketch or cv
Reconstructive Transplantation Research Funding Opportunity for Fiscal Year 2014
One notable addition in the recent Fiscal year 2014 (FY14) Defense Appropriations Act is $15 million (M) to the Department of Defense for the Reconstructive Transplantation Research Program (RTR) to support the science and execution of complex limb and face transplants. This program is administered by the US Army Medical Research and Materiel Command, the Clinical and Rehabilitative Medicine Research Program (CRMRP), through the Office of Congressionally Directed Medical Research Programs (CDMRP) and the Tissue Injury and Regenerative Medicine Project Management Office. News release was issued on June 20, 2014.
No actual Request for Applications is open yet. More on this program: http://cdmrp.army.mil/pubs/press/2014/14rtrppreann.shtml
The Consortium to Alleviate PTSD has a Request for Applications (RFA) out for funding affiliated with their award. Detailed descriptions of the CAP funding opportunity, evaluation criteria, and submission requirements can be found in the Request for Applications available electronically for downloading from the CAP website
Over the past 49 years, the PhRMA Foundation has helped thousands of scientists advance their careers and has inspired new generations to enter biopharmaceutical research. The early-career support provided by the PhRMA Foundation has been a catalyst for our scientists to become leaders in their organizations and fields. Our programs help build a larger pool of highly-trained researchers to meet the growing needs of academic institutions, the government and the research-intensive pharmaceutical industry.
The PhRMA Foundation funds scientists at critical points in their research careers to support and reward innovation in disciplines essential to the development of safe and effective medicines. The PhRMA Foundation offers competitive pre and post doctoral fellowships, sabbatical fellowships, and research starter grants to advance science in pharmacology, toxicology, informatics, pharmaceutics, and health outcomes. The Foundation also offers a Comparative Effectiveness Research Center of Excellence Award.
PhRMA Foundation award recipients will continue to play an instrumental role in substantial achievements in medicine for the benefit of public health and ultimately the patient.
The BUMC Transgenic Core, established in 1995 by Dr. Katya Ravid, has played an important role in the activities of many scientists at our institution. As part of the continual evaluation of all cores, a faculty committee was established to advise Provost Antman and me on the future role of transgenic services at BUMC.
The committee members were unanimously in favor of maintaining a Transgenic Core facility at BU and increasing its capabilities to serve a larger user group. While the committee recognized that implementation of this recommendation will require new investment at a time of fiscal uncertainty, they were convinced that a transgenic core providing state-of-the-art services is essential for maintaining and growing the University’s research portfolio.
After careful consideration of her many leadership commitments, Dr. Ravid has chosen to step down as Scientific Director of the core because of conflicting time commitments. We would like to thank Dr. Ravid for her creative work and efforts on behalf of the institution in establishing and directing the core over the past 20 years. Her insights and efforts contributed to the success of many research projects and grants at BU.
Dr. Kenn Albrecht, a developmental geneticist with broad expertise in the creation and analysis of mouse models of human disease and a collaborator of Dr. Ravid and the Transgenic Core on multiple projects, has agreed to become the new Scientific Director. Please join me in thanking Dr. Ravid for her efforts and Dr. Albrecht for continuing the mission of the Transgenic Core Facility.
Limited Submission Opportunity: Burroughs Wellcome Fund Program for Investigators in the Pathogenesis of Infectious Disease
The Burroughs Wellcome Fund has announced its Investigators in the Pathogenesis of Infectious Disease funding program. This award provides $500,000 over a period of five years to support accomplished investigators at the assistant professor level to study pathogenesis, with a focus on the interplay between human and microbial biology, shedding light on how human and microbial systems are affected by their encounters. The awards are intended to give recipients the freedom and flexibility to pursue new avenues of inquiry and higher-risk research projects that hold potential for significantly advancing the biochemical, pharmacological, immunological, and molecular biological understanding of how microbes and the human body interact.
PROGRAM DESCRIPTION:The Investigators in the Pathogenesis of Infectious Disease program provides opportunities for assistant professors to bring multidisciplinary approaches to the study of human infectious diseases. Areas of particular interest include:
- Cell/Pathogen interactions—studies of host responses at the cell surface, cell signaling in response to infection, microbial persistence in host cells, and other work.
- Host/Pathogen interactions—studies of how host genetics influences resistance and susceptibility to infection, innate and adaptive immune responses to microbes, pathogen modulation of the immune system, and other work.
- Novel routes to disease causation—studies of the role of infectious agents in the etiology of chronic, autoimmune, and immunologic diseases, and other work.
ELIGIBILITY: Candidates must be nominated by accredited, degree-granting institutions in the United States or Canada. A U.S. or Canadian institution, including its medical school, graduate schools, and all affiliated hospitals and research institutes, may nominate up to two candidates. However, institutions that nominate a candidate who holds a Doctorate of Veterinary Medicine (D.V.M.) will be allowed three nominations. Institutions may have a single additional nomination if they nominate a researcher working in pathogenic helminthes, mycology, or reproductive science. Institutions may have one additional nomination if they nominate a member of an underrepresented minority group.
Candidates will generally have an M.D., D.V.M., or Ph.D. degree and must be citizens or permanent residents of the United States or Canada at the time of application. Candidates must have an established record of independent research and hold a tenure-track position as an assistant professor or equivalent at the time of application.
FUNDING INFORMATION: This award provides $500,000 over a period of five years. No more than $20,000 of the award may be used annually for the grantee’s salary support, including fringe benefits. Indirect costs may not be charged against the award. Grantees must devote at least 75 percent of their time to research-related activities.
Jean Kramarik, Senior Program Associate
Burroughs Wellcome Fund
21 T. W. Alexander Drive
Research Triangle Park, NC 27709
BU Internal Deadline: September 9, 2014
Nomination Deadline: November 3, 2014
INTERNAL REVIEW PROCESS: Boston University may nominate two candidates for the award. An internal review committee will select the final nominees. If you would like to apply, please send the following documents, combined into single pdf file, to Diana Lehman (firstname.lastname@example.org) by September 9, 2014:
- A one-page summary of your research
- A letter from your research mentor or departmental chair
- Your email address and your mentor’s email address
- The exact date of your first faculty appointment
- Your CV
A lab notebook is the primary record of research, where scientists document their hypotheses, experiments and initial analysis or interpretation of experiments. The lab notebook serves primarily as a memory aid and a legacy document for future scientific experiments. It is important to understand that a lab notebook is a legal document, which in case of allegations of misconduct or patent disputes, is used to validate a scientist’s findings. Despite its legal significance, there is no established universal standard for the use of lab notebooks.
The purpose of this survey is to learn what types of laboratory notebooks are currently used at BUMC, as well as to determine whether BU should develop guidelines or establish policies regarding the composition of laboratory notebooks campus-wide.
Please take a few minutes to fill out this survey by clicking on the link below:
Your responses will be anonymous. We will only collect some general demographic information from you to make sure the survey represents an adequate cross section of schools, departments and functions at BUMC.
Thank you for your cooperation!
Searle Scholars Program
The Kinship Foundation/Searle Scholars Program has announced its awards for 2015. Boston University is invited to submit only one application. Potential applicants will be reviewed internally to select the final candidate. If you would like to apply, please send your application to Diana Lehman, Office of Clinical Research by August 8, 2014.
The Searle Scholars Program makes grants to selected academic institutions to support the independent research of outstanding early-career faculty in the biomedical sciences and chemistry who have recently been appointed as assistant professors on a tenure-track appointment.
Applicants for awards, which will be activated on July 1, will be expected to be pursuing independent research careers in biochemistry, cell biology, genetics, immunology, neuroscience, pharmacology, and related areas in chemistry, medicine, and the biological sciences. Candidates should have begun their appointment as an independent investigator at the assistant professor level on or after July 1, 2013 The appointment must be their first tenure-track position (or its nearest equivalent) at an invited institution.
Grants are $300,000 for a three-year term with $100,000 payable each year of the grant, subject to the receipt of acceptable progress reports. Generally, the program makes 15 new grants each year.
Internal Deadline: August 8, 2014
Foundation Deadline: September 26, 2014
Douglas M. Fambrough
Searle Scholars Program
14411 Falls Road
Cockeysville, MD 21030
Telephone: (410) 842-7477
Boston University may submit only one application to the Searle Scholars Program. Potential applicants will be reviewed internally to select the final candidate. If you would like to apply, please email the following documents (preferably combined into a single pdf file) to Diana Lehman (email@example.com), Office of Clinical Research by August 8, 2014:
- a one-page summary of your research
- a letter from your research mentor or departmental chair
- your email address and your mentor’s email address
- the exact date of your first faculty appointment
- and your biosketch or cv
The application process for selected candidates requires online submission. A complete award program description and application guidelines are available on the Foundation’s web site at http://www.searlescholars.net/go.php?id=1.
For 2014-15, Susan G. Komen will be offering three types of grants
1) Career Catalyst Research Grants ($450,000 over 3 years).
CCR grants provide unique opportunities for scientists who have held faculty positions for no more than six years at the time of full application to achieve research independence. These grants provide support for hypothesis-driven research projects that have significant potential to advance our understanding of breast cancer, lead to reductions in breast cancer incidence and/or mortality, and move us toward the goal of a world without breast cancer. Awards may be for basic, translational or clinical research. Pre-Application Submission deadline: July 17, 2014.
2) Postdoctoral Fellowship Grants ($180,000 for 2-3 years).
PDF grants seek to attract and support promising scientists embarking on careers dedicated to breast cancer research. These grants provide support for research projects that have significant potential to advance our understanding of breast cancer, lead to reductions in breast cancer incidence and/or mortality, and move us toward the goal of a world without breast cancer. Awards may be for basic, translational, or clinical research. Pre-Application Submission deadline: July 17, 2014
3) Graduate Training in Disparities Research (Up to $135,000 per year for up to 3 years).
GTDR grants seek to establish or to sustain a training program for a minimum of three graduate students who are seeking careers dedicated to understanding and eliminating disparities in breast cancer outcomes across population groups. Pre-Application Submission deadline: July 17, 2014.